Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 11

    1.

    Abnormal MDMX degradation in tumor cells due to ARF deficiency.

    Li X, Gilkes D, Li B, Cheng Q, Pernazza D, Lawrence H, Lawrence N, Chen J.

    Oncogene. 2011 Nov 28. doi: 10.1038/onc.2011.534. [Epub ahead of print]

    PMID:
    22120712
    [PubMed - as supplied by publisher]
    2.

    p14(ARF) inhibits the functions of adenovirus E1A oncoprotein.

    Shen J, Zhang S, Li Y, Zhang W, Chen J, Zhang M, Wang T, Jiang L, Zou X, Wong J, Li X, Cui Y, Wang C.

    Biochem J. 2011 Mar 1;434(2):275-85.

    PMID:
    21133853
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma.

    Li L, Tao Q, Jin H, van Hasselt A, Poon FF, Wang X, Zeng MS, Jia WH, Zeng YX, Chan AT, Cao Y.

    Clin Cancer Res. 2010 Jun 1;16(11):2949-58. Epub 2010 Apr 15.

    PMID:
    20395212
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    p14ARF interacts with DAXX: effects on HDM2 and p53.

    Ivanchuk SM, Mondal S, Rutka JT.

    Cell Cycle. 2008 Jun 15;7(12):1836-50. Epub 2008 Jun 30.

    PMID:
    18583933
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.

    Wang C, Ivanov A, Chen L, Fredericks WJ, Seto E, Rauscher FJ 3rd, Chen J.

    EMBO J. 2005 Sep 21;24(18):3279-90. Epub 2005 Aug 18.

    PMID:
    16107876
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.

    Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA, Xiong Y.

    Mol Cell Biol. 2003 Dec;23(23):8902-12.

    PMID:
    14612427
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2.

    Clark PA, Llanos S, Peters G.

    Oncogene. 2002 Jul 4;21(29):4498-507.

    PMID:
    12085228
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    MDM2 and MDMX can interact differently with ARF and members of the p53 family.

    Wang X, Arooz T, Siu WY, Chiu CH, Lau A, Yamashita K, Poon RY.

    FEBS Lett. 2001 Feb 16;490(3):202-8.

    PMID:
    11223036
    [PubMed - indexed for MEDLINE]
    9.

    An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.

    Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT, Lane DP.

    Oncogene. 2000 May 4;19(19):2312-23.

    PMID:
    10822382
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

    Zhang Y, Xiong Y, Yarbrough WG.

    Cell. 1998 Mar 20;92(6):725-34.

    PMID:
    9529249
    [PubMed - indexed for MEDLINE]
    11.

    The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

    Pomerantz J, Schreiber-Agus N, LiƩgeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA.

    Cell. 1998 Mar 20;92(6):713-23.

    PMID:
    9529248
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk